Điều trị bạch cầu cấp dòng tủy trên bệnh nhân lớn tuổi: Báo cáo kết quả 6 trường hợp

Acute myeloid leukemia (AML) occurs at any age, but common in older patients. Despite considerable progress during recent decades in the therapy of AML, the treatment of AML in the elderly remains a challenge for clinicians. Since April 2011, at Ho Chi Minh Blood Transfusion and Hematology Hospital, the authors have carried out a clinical trial to evaluate the effective and toxicity of the reduced regimen, used in elderly patients (over 60) with AML. Until Feb 2012, 6 patients was enrolled this study. The authors report the results recorded in 6 cases: 5 patients had complete remission, 1 patient had partial remission; 3 of them had relapse after 4-month, 6-month and 9-month CRs.